- Sutro Biopharma (NASDAQ:STRO) has appointed Anne Borgman, M.D., as Chief Medical Officer, effective February 28, 2023.
- Dr. Borgman, most recently served as Vice President and Therapeutic Area Lead, Oncology, Hematology, and Transplant, at Jazz Pharmaceuticals.
- Dr. Borgman brings over 20 years of oncology and hematology drug development experience to Sutro, including extensive regulatory experience in both the U.S. and Europe, leading to nine regulatory approvals.
Sutro Biopharma appoints Borgman as Chief Medical Officer
Recommended For You
More Trending News
About STRO Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
STRO | - | - |
Sutro Biopharma, Inc. |